Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.43 USD | -23.52% | -23.46% | +15.32% |
06:12pm | Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating | MT |
05-08 | Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.32% | 504M | |
+6.35% | 32.61B | |
+22.28% | 7.98B | |
+25.15% | 3.99B | |
-18.21% | 3.13B | |
-19.63% | 1.38B | |
-31.26% | 1.2B | |
+8.00% | 959M | |
-33.44% | 915M | |
-25.64% | 819M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- Craig-Hallum Adjusts LifeMD's Price Target to $15 From $10, Maintains Buy Rating